News & Trends - Pharmaceuticals
hearts4heart and Heart Support Australia partner on global call to governments

Pharma News: Global Heart Hub has spearheaded a collaborative effort, uniting cardiovascular disease (CVD) patient communities, including hearts4heart and Heart Support Australia, alongside thought leaders to develop the inaugural global manifesto advocating for early detection and diagnosis of CVD.
Dr Christian Verdicchio, CEO of Heart Support Australia, said “As a contributor to this document which was formed following our meeting in Barcelona last year, it is clear that there is a need for a global call to action to our governments to seriously address the largest killer in the world through better prevention and awareness campaigns. It is also clear that patient organisations play an important part in advocating for change to policy makers.
“Global Heart Hub should be congratulated for bringing together so many patients organisations globally to identify and address the issue of CVD. We look forward to working with Global Heart Hub in a coordinated approach to continue to advocate for policy change in Australia in conjunction with our local partners and cardiac peak bodies.”
The manifesto was developed through a multi-stakeholder approach, bringing together 125 patient advocates, including 40 CVD patient organisations, along with key opinion leaders and multidisciplinary experts from the World Heart Federation and the European Society of Cardiology (ESC).
Neil Johnson, Executive Director of Global Heart Hub, highlighted the profound impact of delayed detection and diagnosis of CVD on patients and their families.
“For too long, patients and their families have faced the substantial impact of missed and late detection and diagnosis of CVD,” he stated. “Direct patient involvement has been central to the development of this document from concept to development.”
Tanya Hall, CEO of Hearts4heart, echoed similar sentiments, emphasising the transformative potential of the manifesto.
“We really need this manifesto to help guide us as patient organisations to not only map out the work that we do, but also to influence policy makers to put more funding and more focus on cardiovascular care, both in terms of early diagnosis and through to the full treatment pathway,” she remarked.
Professor Fausto Pinto, Immediate Past President of the World Heart Federation, praised the initiative, affirming, “The manifesto is something that we really feel can make a difference. We are working together on a united front to reduce the burden of disease and promote cardiovascular health.”
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Sussan Ley breaks ground as first female opposition leader amid Liberal party shake-up
Sussan Ley has made history as the country’s first female opposition leader, edging out former shadow treasurer Angus Taylor in […]
MoreNews & Trends - MedTech & Diagnostics

New procedure shows durable impact in type 2 diabetes
Medtech company, Endogenex, has unveiled promising data from an Australian clinical trial that could mark a turning point in type […]
MoreNews & Trends - Pharmaceuticals

AI rewrites the script on androgen deprivation therapy in prostate cancer
Artificial intelligence is showing promise in reshaping treatment decisions for men undergoing radiation therapy and androgen deprivation therapy (ADT) for […]
MoreNews & Trends - MedTech & Diagnostics

MSAC to assess CGM funding for expanded access in diabetes management
Applications from Abbott Australasia and Australasian Medical & Scientific Limited (AMSL) for public funding of continuous glucose monitoring (CGM) devices […]
More